Fresenius Kabi s.r.o. secures contract for Antibacterials for systemic use Supplies of the medicinal preparation with the active substance CLINDAMYCIN parenteral form 2025

Czechia, April 15 -- Czechia based Fresenius Kabi s.r.o. has secured contract from Krajska zdravotni, a.s. for Antibacterials for systemic use Supplies of the medicinal preparation with the active substance CLINDAMYCIN parenteral form 2025. The value of the contract is worth 527196000 CZK.

Published by HT Digital Content Services with permission from Pivotal Sources....